Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
ryan.byrne@well.ox.ac.uk

Research groups

Church group: tumour genomics and immunology

Ryan Byrne

PhD

Senior Bioinfomatician

Recent publications

Dual gene set enrichment analysis (dualGSEA); an R function that enables more robust biological discovery and pre-clinical model alignment from transcriptomics data.

Bull C. et al, (2024), Scientific reports, 14

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial

Scanlon E. et al, (2024), ESMO Open, 9, 103930 - 103930

Author Correction: Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Malla SB. et al, (2024), Nature genetics, 56

Pathway level subtyping identifies a slow-cycling biological phenotype associated with poor clinical outcomes in colorectal cancer.

Malla SB. et al, (2024), Nature genetics, 56, 458 - 472

β-Catenin Drives Butyrophilin-like Molecule Loss and γδ T-cell Exclusion in Colon Cancer.

Suzuki T. et al, (2023), Cancer immunology research, 11, 1137 - 1155